Skip to content
Link copied!

達爾膚生醫科技股份有限公司

2024 Sustainability Report

  • Reporting Year:2024

  • Disclosure Period:2024/01/01 ~ 2024/12/31

  • Industry:生技醫療業

  • Capital Range:None

  • Verification Agency:None

  • Verification Standards:GRI準則

  • Assurance Provider:None

  • Assurance Standards:None

Report summary

  • This page summarizes the 2024 sustainability report and ESG report PDF source for 達爾膚生醫科技股份有限公司 (6523).
  • The reporting period is 2024/01/01 to 2024/12/31; industry is 生技醫療業; capital range or filing reason is None.
  • third-party verification or assurance body information is not currently provided; this can be used to review report verification, assurance, and disclosure standards.
  • Compare public disclosure approaches across prior-year and peer reports. Your company’s actual disclosures must still be based on its own data and supporting evidence.

Report details

Company
達爾膚生醫科技股份有限公司(6523)
Reporting Year
2024
Disclosure Period
2024/01/01 to 2024/12/31
Industry
生技醫療業
Third-party information
third-party verification or assurance body information is not currently provided
PDF source
The original ESG report PDF can be downloaded or opened from this page

How to use this report

  • Compare how 達爾膚生醫科技股份有限公司 structured 生技醫療業 sustainability report chapters and material topics in 2024.
  • Confirm the reporting period, third-party verification or assurance information, and downloadable ESG report PDF source.
  • Mark public disclosures and original page numbers that can be referenced as research materials for planning chapters and indicators for your own company.

Historical Reports

Reports from the Same Industry

How can this public report be used as a reference?

Compare chapter structures, metrics, and public disclosure approaches, then check the original page for context. A peer’s disclosure is not evidence about your company; use your own data and supporting documents for actual disclosures.

Check report Build report